At Dynamill Research, we exist to accelerate the next generation of diagnostic innovations with greater predictability and speed.
As a specialized U.S.-based Clinical Research Organization (CRO), we bring our expertise to a rapidly evolving market shaped by advances in molecular diagnostics, artificial intelligence, precision medicine, and innovations in medical technology-including both (therapeutic and diagnostic devices).
In an industry often served by generalized CROs, we offer a different model—one built on diagnostic-specific execution, scientific expertise, regulatory excellence, and a highly collaborative client experience.
Fast. Predictable. Smart. Fast. Predictable. Smart. Fast. Predictable. Smart.
Fast. Predictable. Smart. Fast. Predictable. Smart. Fast. Predictable. Smart.
The $70 billion U.S. diagnostics market is growing fast, but with growth comes complexity. Diagnostic sponsors are facing increasing challenges due to high-volume data, accelerated launch timelines, and complex regulatory pathways. Generic CRO models often fall short in delivering the responsiveness these challenges require.
Dynamill Research bridges this gap by offering dedicated diagnostic trial expertise—designed to simplify the complexity, accelerate execution, and deliver meaningful outcomes for both emerging and established innovators.
Dynamill Research is led by a cross-functional team of scientific, operational, and
regulatory experts who understand the distinct challenges and
opportunities in diagnostic trials. From molecular assay validation to complex multi-
site studies, our team brings both a strategic perspective and hands-on operational
excellence.
Every trial we design is guided by the realities of modern diagnostics, such as high data volume, complex endpoints, urgent timelines, and regulatory intricacies.
Dynamill Research is led by a cross-functional team of scientific, operational, and regulatory experts who understand the distinct challenges and opportunities of diagnostic trials. From molecular assay validation to complex multi-site studies, our team brings both a strategic perspective and day-to-day executional excellence.
Dr. Murtaza HussainOperations Advisor
Joseph CohilC.C.O. (Chief Commercial Officer)
Mohammad MilwalaS.M.O. Partner
Talal KhanHead of Scientific & Clinical Affairs
Aqsa ZamanHead of Quality
Talal KhanHead of Scientific & Clinical Affairs
Bilal PatelHead of Marketing
Aqsa ZamanHead of Quality
Joseph CohilC.C.O. (Chief Commercial Officer)
Aqsa ZamanHead of Quality
Bilal PatelHead of Marketing
Dr. Murtaza HussainOperations Advisor
Talal KhanHead of Scientific & Clinical Affairs
Every trial we design is guided by the realities of modern diagnostics, such as high data volume, complex endpoints, urgent timelines, and regulatory intricacies.
That’s why we’ve built Dynamill Research to be agile, integrated, and accountable. We operate as an extension of your team—focused not just on getting trials done, but on getting them done right.
We don’t generalize. We don’t overcomplicate.
We partner, we execute, and we deliver.
Contact Us
+1877- DYNAMILL (3962 6455)
Our Location
16W285 83rd St. STE D-1 Burr Ridge, IL 60527
Email
info@dynamillcro.com
Social Network
16W285 83rd St. STE D-1 Burr Ridge, IL 60527